Patents Assigned to “SCIENTIFIC CENTER OF ANTI-INFECTIOUS DRUGS” JOINT-STOCK COMPANY
  • Antibacterial agent for treating infectious diseases of bacterial origin
    Patent number: 10251939
    Abstract: The invention relates to medicine, namely to the antimicrobial agent for the treatment of infectious bacterial diseases including hospital infections and drug-resistant TB which represents the ion nanostructured complex (INSC) synthesized from carbohydrates proteins and/or polypeptides (albumins, interleukins, interferons, signaling proteins, etc), which are to enhance the antimicrobial activity in vivo, by activating immune cells that contain at least one terminal amino acid such as Phe, Ala, Val, Ala, Leu, Ile, and others with electron-donor functional groups, iodine and halides of the alkali and alkaline earth elements in the fourth stage at a certain ionic strength; an antibacterial agent increases: the susceptibility of bacteria, including antibiotic-resistant, to antibiotics; activity of monocytes and macrophages; efficiency of antibiotic treatment of hospital infections and drug-resistant TB; it also has antiviral activity, stimulates hematopoietic function of bone marrow; has an antitumor effect and r
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: April 9, 2019
    Assignee: “SCIENTIFIC CENTER OF ANTI-INFECTIOUS DRUGS” JOINT-STOCK COMPANY
    Inventors: Alexandr Ivanovich Ilin, Murat Esengalievich Kulmanov
  • Antibacterial agent for treating infectious diseases of bacterial origin
    Patent number: 10149890
    Abstract: The invention relates to medicine, namely to the antimicrobial agent for the treatment of infectious bacterial diseases including hospital infections and drug-resistant TB which represents the ion nanostructured complex (INSC) synthesized from carbohydrates proteins and/or polypeptides (albumins, interleukins, interferons, signaling proteins, etc), which are to enhance the antimicrobial activity in vivo, by activating immune cells that contain at least one terminal amino acid such as Phe, Ala, Val, Ala, Leu, Ile, and others with electron-donor functional groups, iodine and halides of the alkali and alkaline earth elements in the fourth stage at a certain ionic strength; an antibacterial agent increases: the susceptibility of bacteria, including antibiotic-resistant, to antibiotics; activity of monocytes and macrophages; efficiency of antibiotic treatment of hospital infections and drug-resistant TB; it also has antiviral activity, stimulates hematopoietic function of bone marrow; has an antitumor effect and r
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: December 11, 2018
    Assignee: “SCIENTIFIC CENTER OF ANTI-INFECTIOUS DRUGS” JOINT-STOCK COMPANY
    Inventors: Alexandr Ivanovich Ilin, Murat Esengalievich Kulmanov